Acute severe MR is a medical emergency caused by sudden disruption of the mitral valve apparatus, most commonly from chordal rupture (myxomatous disease), papillary muscle rupture (post-MI), or infective endocarditis (leaflet perforation). It results in acute volume overload on an unprepared LV and LA, leading to pulmonary edema and/or cardiogenic shock. [1-2] Hospital mortality remains 10–40% with papillary muscle rupture, and up to 80% without surgical correction. [3-4]
1. History
- Onset and tempo: Sudden dyspnea, orthopnea, inability to lie flat — often minutes to hours. Ask about preceding chest pain (MI), fever/IVDU (endocarditis), or known mitral valve prolapse (chordal rupture) [1-2]
- Chest pain: Suggests ischemic etiology; inferior STEMI classically associated with posteromedial papillary muscle rupture [3]
- Timing relative to MI: Papillary muscle rupture typically occurs 3–5 days post-transmural infarction [3]
- Preceding illness: Fevers, rigors, dental procedures, new skin lesions → endocarditis [1]
- Prior valve disease: Known MVP, rheumatic heart disease, prior valve surgery, prosthetic valve
- Important negatives: No prior HF symptoms, no chronic exertional dyspnea (distinguishes acute from chronic decompensation)
2. Alarm Features
- Cardiogenic shock: Hypotension, altered mental status, cool extremities, oliguria, elevated lactate [5]
- Flash pulmonary edema: Acute respiratory distress with bilateral crackles, hypoxia, pink frothy sputum
- Absent or soft murmur: The murmur may be short, soft, or absent due to rapid equalization of LA and LV pressures — a classic pitfall [1][3][6]
- Post-MI hemodynamic deterioration: New hypotension with hyperdynamic LV on echo → suspect papillary muscle rupture [1]
- Septic emboli/stigmata of endocarditis: Janeway lesions, Osler nodes, splinter hemorrhages
3. Medications
- Afterload reduction (bridge to surgery):
- Nitroprusside: First-line in normotensive patients — reduces afterload, decreases regurgitant volume, increases forward output [6]
- Dobutamine + nitroprusside: For hypotensive patients — inotropic support combined with afterload reduction [6]
- IV diuretics (furosemide): For pulmonary congestion [7]
- Avoid:
- Phenylephrine and pure vasoconstrictors — increase LV afterload and worsen MR [4]
- Beta-blockers acutely in decompensated state (reduce compensatory tachycardia)
- Endocarditis-related: Empiric IV antibiotics per blood culture sensitivities [6]
- Anticoagulation: Consider if mechanical valve replacement planned
4. Diet
- NPO if surgical intervention anticipated
- Strict fluid restriction in the acute setting to reduce preload and pulmonary congestion
- Sodium restriction once stabilized
5. Review of Systems
- Cardiovascular: Chest pain, palpitations, syncope/presyncope, lower extremity edema
- Pulmonary: Dyspnea severity, orthopnea (number of pillows), PND, cough (pink frothy sputum)
- Infectious: Fevers, chills, night sweats, recent dental work, IVDU, new skin lesions
- Neurologic: Focal deficits (embolic stroke from endocarditis)
- GI/Renal: Decreased urine output, abdominal pain (mesenteric ischemia from low output)
6. Collateral History and Family History
- Collateral: Confirm acuity of symptom onset; prior cardiac history, recent hospitalizations, recent MI or cardiac procedures
- Family history: Connective tissue disorders (Marfan, Ehlers-Danlos) predisposing to myxomatous valve disease and chordal rupture
- Social: IVDU (endocarditis risk), recent dental/surgical procedures
7. Risk Factors
- Papillary muscle rupture: Older age, female sex, first MI with delayed presentation, inferior/lateral STEMI, single-vessel disease (posteromedial PM has single blood supply), CKD, prior HF [3]
- Chordal rupture: Myxomatous mitral valve disease/MVP — most common cause of acute severe MR today [2]
- Endocarditis: IVDU, prosthetic valves, poor dentition, immunosuppression, indwelling catheters
- Less common: Takotsubo cardiomyopathy, myocarditis, postpartum cardiomyopathy, blunt chest trauma [8]
8. Differential Diagnosis
- Ventricular septal rupture (post-MI): Similar timing (3–5 days post-MI), new holosystolic murmur at left sternal border, step-up in O₂ saturation at RV level [3]
- Acute aortic regurgitation: Wide pulse pressure, diastolic murmur, acute HF — distinguish by echo
- Acute decompensated HF (non-valvular): No new murmur, dilated LV with reduced EF on echo
- Cardiac tamponade: Hypotension, JVD, muffled heart sounds, pulsus paradoxus — echo shows effusion [3]
- Massive pulmonary embolism: Hypotension, tachycardia, clear lungs, RV dilation on echo [3]
- Dynamic LVOT obstruction (e.g., Takotsubo, HOCM): Systolic murmur worsened by vasopressors, SAM on echo [3]
- Free wall rupture: Tamponade physiology, PEA arrest post-MI [3]
9. Past Medical History
- Known mitral valve prolapse or myxomatous valve disease
- Prior MI, PCI, or CABG
- History of endocarditis or prosthetic valve
- Connective tissue disorders
- Rheumatic heart disease
- Chronic kidney disease (increases PMR risk) [3]
10. Physical Exam
- Vitals: Tachycardia, hypotension, tachypnea, hypoxia, narrow pulse pressure
- Cardiac:
- Murmur may be soft, decrescendo, or absent — a critical pitfall (rapid LA-LV pressure equalization) [1][6]
- S3 gallop or early diastolic rumble may be the only abnormal finding [6]
- Apical impulse may be non-displaced (normal LV size, unlike chronic MR) [6]
- Pulmonary: Bilateral crackles, wheezing, frothy sputum
- Peripheral: Cool extremities, mottled skin, delayed capillary refill (low output state)
- Endocarditis stigmata: Splinter hemorrhages, Janeway lesions, Osler nodes, conjunctival petechiae
11. Lab Studies
- Troponin: Elevated if ischemic etiology (MI-related PMR)
- BNP/NT-proBNP: Elevated; helps confirm acute HF but may not be markedly elevated early
- Lactate: Elevated in cardiogenic shock — marker of tissue hypoperfusion [5]
- CBC: Leukocytosis (endocarditis, sepsis)
- Blood cultures (≥2 sets): If endocarditis suspected — obtain before antibiotics
- BMP/CMP: Renal function (cardiorenal syndrome), electrolytes
- Coagulation studies: Pre-surgical planning
- ABG: Assess oxygenation and acid-base status
- Procalcitonin: May help differentiate infectious vs non-infectious etiology
12. Imaging
- TTE (first-line): Evaluate LV/RV function, PA pressure, mechanism of MR. Key findings: [1][8]
- Flail leaflet or ruptured papillary muscle
- Hyperdynamic LV with low forward output
- Color Doppler jet may be deceptively small and eccentric — MR severity is frequently underestimated
- Systolic flow reversal in pulmonary veins is helpful
- TEE: Indicated when TTE is non-diagnostic or equivocal — superior for detecting papillary muscle rupture, vegetations, annular abscess, and flail segments [1][6]
- CXR: Pulmonary edema (bilateral infiltrates, cephalization, Kerley B lines), normal cardiac silhouette (unlike chronic MR)
- Coronary angiography: If ischemic etiology suspected and patient is hemodynamically stable enough [2][6]
13. Special Tests
- Point-of-care ultrasound (POCUS): Rapid bedside assessment — look for B-lines (pulmonary edema), hyperdynamic LV, flail leaflet, pericardial effusion [3]
- Pulmonary artery catheterization: Large V waves on PCWP tracing; helps differentiate from VSD (step-up in O₂ saturation) and guides hemodynamic management
- IREMMI Clinical Classification: [5]
- Type 1: Cardiogenic shock (MAP <90, elevated lactate, vasoactive drugs/MCS needed)
- Type 2: Refractory pulmonary edema, MAP >90, low output
- Type 3: Intermittent pulmonary edema, MAP >90
- Type 4: Mild-moderate HF, oral diuretics
14. ECG
- Ischemic etiology: ST elevation (inferior leads II, III, aVF in posteromedial PMR), ST depression, Q waves [1]
- Sinus tachycardia: Expected compensatory response
- Atrial fibrillation: May be present, especially with atrial functional MR [4]
- Left atrial enlargement: Unlikely in acute MR (no time for remodeling) — its presence suggests chronic component
- Normal ECG does not exclude acute MR
15. Assessment
- Acute severe MR is a surgical emergency when caused by papillary muscle rupture or severe chordal rupture [1][3]
- The diagnosis is frequently missed or delayed because the clinical presentation differs substantially from chronic MR — the murmur is soft/absent, the color Doppler jet is small, and the LV is not dilated [8-9]
- Key diagnostic pearl: A hyperdynamic LV on echo in a patient with acute pulmonary edema or cardiogenic shock should raise immediate suspicion for acute severe MR, even without a prominent murmur or large color jet [1][8]
- Mortality without surgery approaches 80%; with surgery, 19–53% [4]
16. Treatment Plan
Initial Stabilization
- ABCs, high-flow O₂, prepare for intubation if needed
- Positive pressure ventilation (NIV or invasive): Reduces LV afterload, reduces MR, improves forward flow [4]
- IV access, arterial line, continuous monitoring
Medical Therapy (bridge to definitive intervention)
- Nitroprusside (if normotensive): Start 0.3 mcg/kg/min, titrate to effect — reduces afterload and regurgitant volume [6]
- Dobutamine (if hypotensive): 2–20 mcg/kg/min — inotropic support [6]
- IV furosemide: For pulmonary congestion [7]
- Avoid phenylephrine and pure vasoconstrictors [4]
Mechanical Circulatory Support
- IABP: Reasonable first-line MCS — increases forward output, reduces regurgitant fraction, stabilizes hemodynamics pre-operatively [4][6]
- Consider advanced MCS if refractory shock
Definitive Intervention
- Emergency mitral valve surgery (repair preferred, replacement if necessary) — treatment of choice for acute severe primary MR [1][3]
- Papillary muscle rupture: Chordal-sparing MV replacement is standard; repair considered for partial PMR with stable hemodynamics [3]
- Concomitant CABG if obstructive CAD present [3]
- Transcatheter edge-to-edge repair (TEER/MitraClip): Alternative in patients with prohibitive surgical risk, as part of a Heart Team approach [3][7]
- Endocarditis: Targeted IV antibiotics; surgery for hemodynamic instability, large vegetations, embolic events, or abscess [1]
17. Disposition
- All patients with acute severe MR require admission, typically to the ICU/CCU [4]
- Immediate cardiothoracic surgery consultation for papillary muscle rupture — surgical emergency, preferably within 24 hours [3]
- Cardiology consultation for all cases — echocardiography, hemodynamic management, Heart Team decision-making
- Infectious disease consultation if endocarditis suspected
- Patients with mild-moderate acute MR who stabilize may be managed on a monitored floor with close follow-up [5]
18. Follow Up / Return Precautions
- Post-surgical: Serial echocardiography to assess valve function, LV recovery, and for prosthetic valve complications
- Endocarditis: Complete antibiotic course (4–6 weeks IV); repeat blood cultures to document clearance
- Return precautions (if rare outpatient management of mild acute MR):
- Expected course: Acute severe MR without intervention carries very high mortality; with successful surgery, significant improvement in hemodynamics and symptoms is expected, though operative mortality remains substantial [1][4]
- Long-term: Anticoagulation management if mechanical valve placed; endocarditis prophylaxis per guidelines; cardiology follow-up within 1–2 weeks post-discharge
Images
References
1. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. — Otto CM, Nishimura RA, Bonow RO, et al. Journal of the American College of Cardiology. 2021.
2. Acute Mitral Regurgitation With and Without Acute Heart Failure. — Boudoulas KD, Triposkiadis F, Koenig S, et al. Heart Failure Reviews. 2023.
3. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association. — Damluji AA, van Diepen S, Katz JN, et al. Circulation. 2021.
4. Acute Decompensated Valvular Disease in the Intensive Care Unit. — Miller PE, Senman BC, Gage A, et al. JACC. Advances. 2024.
5. Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5. — Estévez-Loureiro R, Lorusso R, Taramasso M, et al. Journal of the American College of Cardiology. 2024.
6. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. — Bonow RO, Carabello BA, Chatterjee K, et al. Journal of the American College of Cardiology. 2008.
7. Transcatheter Mitral Edge-to-Edge Repair for Treatment of Acute Mitral Regurgitation. — Shuvy M, Maisano F, Strauss BH. The Canadian Journal of Cardiology. 2023.
8. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance. — Zoghbi WA, Adams D, Bonow RO, et al. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 2017.
9. Acute Mitral Regurgitation. — Watanabe N. Heart. 2019.